Peripheral artery disease (PAD) affects over 113 million people worldwide and is a marker of systemic atherosclerosis ...
New guidance for clinicians for the evaluation and management of patients with lower extremity peripheral artery disease (LE PAD) was published in May. The 2024 ACC/AHA guideline for LE PAD, the first ...
Arletta Pharma announces positive results from phase II CDU study of Lybrido combination targeting female sexual dysfunction: Amsterdam, the Netherlands Monday, March 30, 2026, 16 ...
Results validate dose selection and de-risk pivotal trial in US and Europe clinical development program Amsterdam, the Netherlands, March 27, 2026 – Arletta Pharma Solutions, a pharmaceutical company ...
More than 60% average improvement in clitoral blood flow observed with both dose-combinations Statistical significance achieved with new high dose-combination despite small sample size Results ...
Statistical significance achieved with new high dose-combination despite small sample size Results validate dose selection and de-risk pivotal trial in US and Europe clinical development program ...
The importance of corrosion protection is not theoretical: failures linked to long-term deterioration in aggressive service environments, including the 2018 Morandi Bridge collapse in Genoa, have ...
A SIMPLE geometric formula has shown promise in how clinicians assess carotid plaque volume, potentially offering a more accurate way to track atherosclerotic burden using routine ultrasound imaging.